נקסיום טבליות 40 מג ישראל - עברית - Ministry of Health

נקסיום טבליות 40 מג

taro international ltd, israel - esomeprazole - טבליה - esomeprazole 40 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.

נקסיום טבליות  40 מג ישראל - עברית - Ministry of Health

נקסיום טבליות 40 מג

astrazeneca (israel) ltd - esomeprazole - טבליה - esomeprazole 40 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.

QH סרום במבוק לשיער ישראל - עברית - Ministry of Health

qh סרום במבוק לשיער

ג'ויה מעבדות לקוסמטיקה בעמ - טיפוח השיער

זנטק זריקות 25 מגמל ישראל - עברית - Ministry of Health

זנטק זריקות 25 מגמל

glaxo smith kline (israel) ltd - ranitidine as hydrochloride - תמיסה להזרקה - ranitidine as hydrochloride 25 mg/ml - ranitidine - ranitidine - treatment of :- duodenal ulcer,- benign gastric ulcer,- post operative ulcer,- oesophageal reflux disease,- zollinger-ellison syndrome.before general anaesthesia in patients considered to be at risk of acid aspirationprophylaxis of stress ulceration in seriously ill patients.

זנטק סירופ ישראל - עברית - Ministry of Health

זנטק סירופ

glaxo smith kline (israel) ltd - ranitidine as hydrochloride - סירופ - ranitidine as hydrochloride 150 mg / 10 ml - ranitidine - ranitidine - h2 receptor antagonist. for treatment of duodenal ulcer and benign gastric ulcer, including that associated with nsaid agents. post-operative ulcer, oesophageal reflux disease and zollinger-ellison syndrome. prophylaxis of stress ulceration in seriously ill patients. before general anaesthesia in patients considered to be of risk acid aspiration (mendelson's syndrome).

זרידקס 150 ישראל - עברית - Ministry of Health

זרידקס 150

dexcel ltd, israel - ranitidine as hydrochloride - טבליה - ranitidine as hydrochloride 150 mg - ranitidine - ranitidine - for the treatment of duodenal ulcer, benign gastric ulcer, oesophageal reflux disease and ulcers associated with the use of non-steroidal anti-inflammatory agents. for the prophylaxis of haemorrhage from stress ulceration.

זרידקס 300 ישראל - עברית - Ministry of Health

זרידקס 300

dexcel ltd, israel - ranitidine as hydrochloride - קפליות - ranitidine as hydrochloride 300 mg - ranitidine - ranitidine - treatment of duodenal ulcer and beingn gastric ulcer, esophageal reflux disease, peptic ulcers associated with the use of non-steroidal anti-inflammatory agent (nsaids). prophylaxis of gastrointestinal hemorrhage from stress ulceration.

קונטרולוק 20 מג ישראל - עברית - Ministry of Health

קונטרולוק 20 מג

takeda israel ltd - pantoprazole - טבליה - pantoprazole 20 mg - pantoprazole - pantoprazole - treatment of reflux oesophagitis and associated symptoms (e.g. hearburn acid regurgitation pain on swallowing) . for long-term management and prevention of relapse in reflux oesophagitis. prevention of gastroduodenal ulcers induced by non-steroidal anti-inflammatory drugs (nsaids) in patients at risk with a need for continuous nsaids treatment.